We further identified IRF4 as a key regulator of BCL2‐induced SOX9 expression, and ChIP‐seq confirmed that IRF4 is a key transcription factor for SOX9 in DLBCL. The gene discussed is IRF4; the disease is diffuse large B-cell lymphoma.